HCMV glycoprotein B subunit vaccine efficacy was mediated by non-neutralizing antibody effector functions
C. S. Nelson, T. Huffman, E. Cisneros de la Rosa, G. Xi, N. Vandergrift, R. F. Pass, J. Pollara, S. R. Permar
This paper shows that the HCMV gB/MF59 vaccine's 50% efficacy is due to non-neutralizing antibodies that mediate virion phagocytosis, not neutralization.
bioRxiv · Jan 11, 2018Immunology